Knowledge Base
Technology
Hardware
Software
Quality Control
Sample
Becoming and being a FIDA user
Protein analysis and characterisation
Consumables
Protein stability and storage

How to analyse bispecific antibodies?

Flow Induced Dispersion Analysis (FIDA) characterises bispecific antibodies in solution by measuring the hydrodynamic radius of a fluorescently labelled antigen as it forms binary and ternary complexes with the antibody and the second antigen. A rapid confirmation approach verifies binary and ternary complex formation, and a complete biophysical characterisation gives the size of the labelled antigen, the binary and ternary complexes, the affinities and the cooperativity.

Welcome to our instructional guide on using the Fida instrument for assaying bispecific antibodies. This guide complements our video demonstration, providing step-by-step details for both the experimental setup and data analysis. Let's dive into the terminologies and methodologies for executing these assays effectively.

Terminologies

  • Indicator: The fluorescent molecule whose hydrodynamic radius is being measured.
  • Analyte: The compound that is titrated in the experiment.

Methodologies for Fida experiments

  1. Premix method: Involves pre-mixing equal amounts of indicator and analyte in vials before injection.
  2. Capillary mix (Capmix) method: Utilises a single indicator vial and multiple analyte vials. Mixing occurs in the capillary by the Fida instrument.
  3. Capillary dissociation (CapDis) method: Consists of a titration of mixed indicator and analyte vials and a single buffer vial. The complex is injected into a buffer.
  4. Capillary flow (Capflex) method: Primarily used for liquid phase separation and condensate analysis (optional in most cases).

The formats are described in Which FIDA assay format should you use?

Ternary complex assay setup for bispecific antibodies

  1. Rapid confirmation approach: Ideal for quick verification of binary and ternary complex formation. Uses the CapDis method. Plate setup includes various indicator vials mixed with analyte and a single buffer vial. Measure sizes of labelled antigen mixed with unlabelled antigen, labelled antigen with bispecific antibody, and labelled antigen in presence of both bispecific antibody and excess unlabelled antigen.
  2. Complete biophysical characterisation: Suitable for thorough analysis of interesting bispecific candidates. Can be executed as either a Premix or a Capmix experiment. Essential to label one of the two antigens fluorescently. The experiment measures various parameters, including the size of labelled antigen, binary and ternary complexes, affinities, and cooperativity.

Data analysis using Fida software

  1. Loading data: Access the data analysis tab and load data files for analysis.
  2. Evaluating and fitting data: Select appropriate time intervals and fit data for single or multiple species. Utilise auto mode for fitting multiple data points efficiently. Manually evaluate and correct each fit, if necessary.
  3. Finalising the analysis: Compensate for viscosity and observe fluorescence areas. Select the ternary complex model and input initial parameters. Apply the model and fit the binding curve for detailed results.

The ternary complex model and its cooperativity term are explained in Which binding model should you use to fit FIDA affinity data?

Conclusion: This guide provides a detailed walkthrough for conducting and analysing bispecific antibody assays using the Fida instrument. By following these steps, you can efficiently confirm the formation of binary and ternary complexes and perform a complete biophysical characterisation of your samples.

What results has FIDA given for bispecific antibodies?

In the poster Rapid sizing and characterization of bispecific antibodies, co-authored by researchers from DTU Bioengineering and Fida Biosystems, FIDA used 40 nL of sample per measurement to determine binding affinities (KD of 7.8 nM and 0.3 nM), complex size and a cooperativity value of 1.6, with sixty samples analysed automatically in 12 hours.

In the study Immobilization-Free Binding and Affinity Characterization of Higher Order Bispecific Antibody Complexes Using Size-Based Microfluidics, stepwise size increases of a labelled antigen confirmed simultaneous bispecific binding, and titrations gave the equilibrium dissociation constant of each binding event, across diverse bispecific antibody architectures and valencies.

Frequently asked questions

Do you need to immobilise the antibody or antigen?

No. FIDA measures binary and ternary complex formation in solution, without attaching molecules to a surface.

Which molecule is labelled?

One of the two antigens is labelled fluorescently and acts as the indicator.

Related resources

Want to see more bispecific antibody work with FIDA? See the application note Rapid Sizing And Characterization of Bispecific Antibodies using nL of Sample, the publication Generation of robust bispecific antibodies through fusion of single-domain antibodies on IgG scaffolds: a comprehensive comparison of formats (mAbs, 2023) and the poster Advanced tools for characterizing diverse bispecific antibodies formed through fusion of single-domain antibodies onto IgG scaffolds.

New to FIDA for antibodies? The engineered antibodies page shows the application, What is hydrodynamic radius? explains the size FIDA measures, and What is KD (dissociation constant)? explains the affinities. To find out whether FIDA fits your bispecific programme, book a discovery call.